GILEAD SCIENCES, INC. (GILD) › Operating IncomeGILEAD SCIENCES, INC. (GILD) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2007: $2.16B2008: $2.68B2009: $3.53B2010: $3.96B2011: $3.79B2012: $4.01B2013: $4.52B2014: $15.27B2015: $22.19B2016: $17.63B2017: $14.12B2018: $8.20B2019: $4.29B2020: $4.07B2021: $9.92B2022: $7.33B2023: $7.61B2024: $1.66B2025: $10.02B$10.02B2007Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025$10.02B+503.0%2024$1.66B-78.1%2023$7.61B+3.8%2022$7.33B-26.1%2021$9.92B+143.6%2020$4.07B-5.0%2019$4.29B-47.7%2018$8.20B-41.9%2017$14.12B-19.9%2016$17.63B-20.5%2015$22.19B+45.4%2014$15.27B+237.4%2013$4.52B+12.8%2012$4.01B+5.8%2011$3.79B-4.4%2010$3.96B+12.3%2009$3.53B+31.8%2008$2.68B+23.7%2007$2.16B—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share